Tim Anderson
Stock Analyst at B of A Securities
(0.32)
# 1765
Out of 5,291 analysts
31
Total ratings
62.50%
Success rate
8.22%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Aardvark Therapeutic... | Maintains: Strong Buy | 22 26 | 7.95 | 227.04% | 2 | Mar 27, 2025 | |
Johnson & Johnson | Maintains: Neutral | 159 171 | 163.6 | 4.52% | 4 | Mar 5, 2025 | |
Gilead Sciences | Maintains: Strong Buy | 116 126 | 111.78 | 12.72% | 2 | Mar 5, 2025 | |
Amgen | Maintains: Underperform | 275 294 | 306.93 | -4.21% | 4 | Mar 5, 2025 | |
AbbVie | Maintains: Neutral | 200 223 | 205.15 | 8.7% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 38 | 27.93 | 36.05% | 1 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 41 34 | 31.12 | 9.25% | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 118 112 | 89.18 | 25.59% | 4 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 29 | 25.19 | 15.13% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 63 | 60.09 | 4.84% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 178 | 138.4 | 28.61% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Underperform | 565 | 637.75 | -11.41% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 997 | 820.02 | 21.58% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 1 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 1 | Sep 22, 2017 |